Gauss’ flagship product is the Triton fluid management system, which runs on Apple’s iPad and calculates blood loss in surgical sponges by merely photographing them, the Los Altos, Calif.-based company said.
The system was recently upgraded with the ability to use the same camera function to calculate blood loss in surgical suction containers.
The system was FDA cleared for sponge blood loss calculation in May 2014, and won 510(k) clearance for suction container blood loss calculation in March this year.
The money comes from 14 unnamed investors, according to the filing. LifeForce Ventures, Promus Ventures and Taube Investment Partners as well as an unnamed “group of experienced healthcare pioneers” are listed as backers on the company’s site.